Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 1133

BillFederalSenateIn Committee
Cardiovascular Advances in Research and Opportunities Legacy Act
About This Bill
Committee
Latest Action · April 15, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1984; text: CR S1985)
Congress
117th (2021–2023)
Introduced
April 15, 2021
Cosponsors (2)
1D 1R
View PDF ↗

Summary

Highlight any text to annotate
Cardiovascular Advances in Research and Opportunities Legacy Act This bill expands research on valvular heart disease and its treatment. This disease is caused by damage to or disease affecting any valve that controls blood flow in the heart. The National Institutes of Health must consult with the National Heart, Lung, and Blood Institute to conduct or support research on the disease, including on mitral valve prolapse. This occurs when the valve between the chambers of the left side of the heart seals improperly. The Centers for Disease Control and Prevention (CDC) must develop best practices to treat valvular heart disease. The CDC may also carry out other projects to increase awareness of and reduce deaths from the disease.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.